These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 25913118)
21. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII. Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787 [TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII. Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates. Küçükbay H; Buğday N; Küçükbay FZ; Berrino E; Bartolucci G; Del Prete S; Capasso C; Supuran CT Bioorg Chem; 2019 Mar; 83():414-423. PubMed ID: 30419497 [TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998 [TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives. Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides. Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519 [TBL] [Abstract][Full Text] [Related]
28. Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors. Akocak S; Lolak N; Bua S; Supuran CT J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1575-1580. PubMed ID: 30296852 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors. Ceruso M; Antel S; Scozzafava A; Supuran CT J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500 [TBL] [Abstract][Full Text] [Related]
30. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184 [TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides. Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190 [TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides. Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130 [TBL] [Abstract][Full Text] [Related]
34. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366 [TBL] [Abstract][Full Text] [Related]
35. Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII. Supuran CT; Maresca A; Gregáň F; Remko M J Enzyme Inhib Med Chem; 2013 Apr; 28(2):289-93. PubMed ID: 22299577 [TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase inhibitory activity of sulfonamides and carboxylic acids incorporating cyclic imide scaffolds. Abdel-Aziz AA; El-Azab AS; Ceruso M; Supuran CT Bioorg Med Chem Lett; 2014 Nov; 24(22):5185-9. PubMed ID: 25442309 [TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides. Zimmerman S; Innocenti A; Casini A; Ferry JG; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2004 Dec; 14(24):6001-6. PubMed ID: 15546717 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of aminocyanopyrazoles via a multi-component reaction and anti-carbonic anhydrase inhibitory activity of their sulfamide derivatives against cytosolic and transmembrane isoforms. Allouche F; Chabchoub F; Carta F; Supuran CT J Enzyme Inhib Med Chem; 2013 Apr; 28(2):343-9. PubMed ID: 23013533 [TBL] [Abstract][Full Text] [Related]
40. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors. Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]